Company / Capital Expenditures
Cencora Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$668.0M
FY2025
5-year range
$310.2M / $668.0M
FY2021-FY2025
Trend
+37.1%
vs FY2024
Sector context
#16 of 150
Health Care
What the data says
Cencora's capital expenditures of $668M is higher than 89% of companies in the Health Care sector (FY2025). Capital Expenditures has increased for 4 consecutive years, from $310M in FY2021 to $668M in FY2025.
Based on SEC 10-K filings.
$668M in FY2025 with a 5-year CAGR of +12.6%. Top quartile in the Health Care sector.
Improved from $438M to $668M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +21.8%
- 5-Year CAGR
- +12.6%
- 10-Year CAGR
- -
Sector benchmark
+146.4% above sector average
Key checks
Key Insights
- Cencora's capital expenditures has grown for 4 consecutive years.
- 5-year CAGR of +12.6%, indicating consistent growth.
- In FY2025, capital expenditures increased 37.1% year-over-year.
- Ranks #16 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.32 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $668.0M | +37.1% |
| FY2024 | $487.2M | +11.2% |
| FY2023 | $438.2M | +18.5% |
| FY2022 | $369.7M | +19.2% |
| FY2021 | $310.2M | -16.1% |
| FY2020 | $369.7M | +19.2% |
| FY2019 | $310.2M | -7.8% |
| FY2018 | $336.4M | -27.9% |
| FY2017 | $466.4M | +0.4% |
| FY2016 | $464.6M | +100.6% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026